Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Clarus Ventures III GP, L.P. — IT&E INTERNATIONAL GROUP insider: 1 transactions · InsiderLens

Home / Insiders / Clarus Ventures III GP, L.P.

Clarus Ventures III GP, L.P.

10% owner at Talaris Therapeutics, Inc. · on record since May 14, 2021
10% owner at Forty Seven, Inc. · on record since Jun 27, 2018
10% owner at IT&E INTERNATIONAL GROUP · on record since Jun 25, 2018
10% owner at Gritstone Oncology, Inc. · on record since Sep 27, 2018
10% owner at Entasis Therapeutics Holdings Inc. · on record since Sep 25, 2018
General Partner at Gritstone Oncology, Inc. · on record since Oct 2, 2018
10% owner at Annexon, Inc. · on record since Jul 30, 2020
10% owner at CALIFORNIA COASTAL COMMUNITIES INC · on record since Sep 25, 2020
10% owner at Praxis Precision Medicines, Inc. · on record since Oct 22, 2020
10% owner at EPIX Pharmaceuticals, Inc. · on record since Oct 1, 2020
10% owner at Imago BioSciences, Inc. · on record since Jul 20, 2021

Insider trading activity of Clarus Ventures III GP, L.P.

Transactions on record: 1; since May 22, 2019

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing May 22, 2019

Figures computed from official regulatory filings — methodology.

Companies where Clarus Ventures III GP, L.P. has traded

IT&E INTERNATIONAL GROUP1 tx · May 22, 2019

Track record of Clarus Ventures III GP, L.P.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Clarus Ventures III GP, L.P.

Co-insiders of Clarus Ventures III GP, L.P.

Clarus Lifesciences III, L.P.Annexon, Inc. +9
Blackstone Clarus III L.L.C.Annexon, Inc. +8
Blackstone Group L.P.Annexon, Inc. +8
Blackstone Group Management L.L.C.Annexon, Inc. +8
Blackstone Holdings I/II GP IncAnnexon, Inc. +8
Blackstone Holdings II L.P.Annexon, Inc. +8
SCHWARZMAN STEPHEN AAnnexon, Inc. +8

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Requadt ScottEntasis Therapeutics Holdings Inc. +4

Clarus Ventures III, LLCEntasis Therapeutics Holdings Inc. +3

GALAKATOS NICHOLASEntasis Therapeutics Holdings Inc. +3

HENNER DENNISEntasis Therapeutics Holdings Inc. +2

Simon NicholasEntasis Therapeutics Holdings Inc. +2

Blackstone Holdings I L.P.Praxis Precision Medicines, Inc. +1

CLARK IAN TForty Seven, Inc. +1

Green JeremyAnnexon, Inc. +1

Heron Patrick JEntasis Therapeutics Holdings Inc. +1

LIPTAK ROBERTEntasis Therapeutics Holdings Inc. +1

MACKAY GEOFFREYIT&E INTERNATIONAL GROUP +1

Norden GregoryEntasis Therapeutics Holdings Inc. +1

Novo A/SEntasis Therapeutics Holdings Inc. +1

Redmile Group, LLCAnnexon, Inc. +1

WHEELER KURTEntasis Therapeutics Holdings Inc. +1

ACKERMANN CHRISTINACALIFORNIA COASTAL COMMUNITIES INC

Adage Capital Management, L.P.Praxis Precision Medicines, Inc.

Agarwala SandipTalaris Therapeutics, Inc.

Agarwal ShefaliGritstone Oncology, Inc.

ALBERTS KELLYIT&E INTERNATIONAL GROUP

Allen Andrew RGritstone Oncology, Inc.

ALLOCCA TONYIT&E INTERNATIONAL GROUP

Altarac DavidEntasis Therapeutics Holdings Inc.

Aphale JayantGritstone Oncology, Inc.

Arbuckle Stuart APraxis Precision Medicines, Inc.

Arenberg MichaelImago BioSciences, Inc.

ARENS GEOFFREY WCALIFORNIA COASTAL COMMUNITIES INC

ARTIS DEAN RICHARDAnnexon, Inc.

ASTRAZENECA ABEntasis Therapeutics Holdings Inc.

ASTRAZENECA PLCEntasis Therapeutics Holdings Inc.

ASTRUE MICHAEL JEPIX Pharmaceuticals, Inc.

Atchinson RobertPraxis Precision Medicines, Inc.

Atlas Venture Associates Opportunity I, LLCIT&E INTERNATIONAL GROUP

Atlas Venture Associates Opportunity I, L.P.IT&E INTERNATIONAL GROUP

Atlas Venture Associates X, LLCIT&E INTERNATIONAL GROUP

ATLAS VENTURE ASSOCIATES X, L.P.IT&E INTERNATIONAL GROUP

Atlas Venture Fund X, L.P.IT&E INTERNATIONAL GROUP

Atlas Venture Opportunity Fund I, L.P.IT&E INTERNATIONAL GROUP

Avruch StevenIT&E INTERNATIONAL GROUP

Bain Capital Life Sciences Fund, L.P.Annexon, Inc.

Bain Capital Life Sciences Investors, LLCAnnexon, Inc.

Bain Capital Life Sciences Partners, LPAnnexon, Inc.

BALL KRISTINE MForty Seven, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
IT&E INTERNATIONAL GROUP	May 22, 2019	Other	-1,481,163	—	—	SEC